HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Entecavir (Primary) ; Peginterferon alfa-2a (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 27 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Sep 2013 New source identified and integrated (Mayo Clinic: 11-000706).